+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

Clinical Trials Sector Scorecard - Thematic Research - Product Thumbnail Image

Clinical Trials Sector Scorecard - Thematic Research

  • Report
  • October 2021
  • 24 Pages
  • Global
From
Kidney Disease (Nephropathy) - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Kidney Disease (Nephropathy) - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • October 2021
  • 3375 Pages
  • Global
From
Osteoporosis: Global Drug Forecast and Market Analysis to 2027 - Product Thumbnail Image

Osteoporosis: Global Drug Forecast and Market Analysis to 2027

  • Report
  • April 2018
  • 195 Pages
  • Global
From
Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2020 - Product Thumbnail Image

Congestive Heart Failure (Heart Failure) - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 631 Pages
  • Global
From
Market Access, Pricing and Reimbursement of Oncology Medicines in the 5EU - Product Thumbnail Image

Market Access, Pricing and Reimbursement of Oncology Medicines in the 5EU

  • Report
  • September 2018
  • 162 Pages
  • Global
From
Thematic Intelligence - The Impact of Inflation on the Healthcare Sector - H2 2023 - Product Thumbnail Image

Thematic Intelligence - The Impact of Inflation on the Healthcare Sector - H2 2023

  • Report
  • December 2023
  • 79 Pages
  • Global
From
Company Snapshots: UK Pharmaceuticals - Product Thumbnail Image

Company Snapshots: UK Pharmaceuticals

  • Newsletter
  • May 2025
  • 35 Pages
  • United Kingdom
From
Company Snapshots: US Pharmaceuticals - Product Thumbnail Image

Company Snapshots: US Pharmaceuticals

  • Newsletter
  • May 2025
  • 35 Pages
  • United States
From
2021 What's Ahead for the Pharmaceutical Industry? - Emerging Opportunities and Growth Strategies for Suppliers - Product Thumbnail Image

2021 What's Ahead for the Pharmaceutical Industry? - Emerging Opportunities and Growth Strategies for Suppliers

  • Report
  • October 2021
  • Global
From
Industry Snapshots: US Pharmaceuticals - Product Thumbnail Image

Industry Snapshots: US Pharmaceuticals

  • Newsletter
  • May 2025
  • 50 Pages
  • United States
From
Industry Snapshots: UK Pharmaceuticals - Product Thumbnail Image

Industry Snapshots: UK Pharmaceuticals

  • Newsletter
  • May 2025
  • 50 Pages
  • United Kingdom
From
Non Receptor Tyrosine Protein Kinase TYK2 (TYK2 or EC 2.7.10.2) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Non Receptor Tyrosine Protein Kinase TYK2 (TYK2 or EC 2.7.10.2) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 125 Pages
  • Global
From
Bullous Pemphigoid Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Bullous Pemphigoid Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • November 2022
  • 55 Pages
  • Global
From
Rheumatoid Arthritis (RA) Therapy Area Report - Product Thumbnail Image

Rheumatoid Arthritis (RA) Therapy Area Report

  • Report
  • February 2022
  • 65 Pages
  • Global
Pharmaceutical Industry in the United States 2022 - Product Thumbnail Image

Pharmaceutical Industry in the United States 2022

  • Report
  • September 2022
  • 150 Pages
  • United States
From
Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 4 or C5) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Complement C5 (C3 And PZP Like Alpha 2 Macroglobulin Domain Containing Protein 4 or C5) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 168 Pages
  • Global
From
Lung Transplant Rejection Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Lung Transplant Rejection Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 51 Pages
  • Global
From
20s Proteasome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

20s Proteasome Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • September 2022
  • 89 Pages
  • Global
From
Migraine - Pipeline Review, H2 2020 - Product Thumbnail Image

Migraine - Pipeline Review, H2 2020

  • Drug Pipelines
  • November 2020
  • 342 Pages
  • Global
From
Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts - Product Thumbnail Image

Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts

  • Report
  • December 2018
  • 180 Pages
  • Global
From
Loading Indicator